Cook Jennifer E.

CIK 00017543713 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001754371

Recent Transactions

43 trades

Tax Payment
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2025-08-08$111.25/sh−1,805→ 10,837 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2025-08-07+3,507→ 12,642 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2025-06-20+8,425→ 8,425 total
Award
BridgeBio Pharma, Inc.$BBIO
Common Stock
2025-06-20+6,589→ 13,741 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2025-06-03+18,111→ 18,111 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2025-06-03+6,037→ 26,075 total
Tax Payment
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2024-08-06$111.35/sh−1,484→ 9,135 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2024-08-02+3,731→ 10,619 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (Right to Buy)
2024-06-21+26,014→ 26,014 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-06-06$21.73/sh−1,458→ 20,038 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-05-31+17,901→ 17,901 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2024-05-31+5,967→ 21,496 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2023-12-04$119.27/sh−417→ 6,888 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2023-08-14$138.16/sh−1,241→ 7,305 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2023-08-11+3,075→ 8,546 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2023-06-21+51,501→ 51,501 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-06-01+12,649→ 12,649 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2023-06-01+4,216→ 15,529 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2022-12-02$154.68/sh−420→ 5,471 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2022-08-08$152.32/sh−1,089→ 5,891 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2022-08-05+2,561→ 6,980 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2022-06-22+104,921→ 104,921 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2022-06-02+17,959→ 17,959 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2022-06-02+5,986→ 11,313 total
Sale
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2021-12-02$121.30/sh−417→ 4,419 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2021-11-16+3,576→ 7,152 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2021-11-16−3,576→ 0 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2021-07-29+2,246→ 4,836 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2021-06-17+38,895→ 38,895 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2021-06-02+6,222→ 6,222 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2021-06-02+2,074→ 5,327 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2021-06-01+3,253→ 3,253 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Restricted Stock Units
2021-06-01−3,253→ 0 total
Award
Jazz Pharmaceuticals plc$JAZZ
Non-Qualified Stock Option (right to buy)
2021-02-25+6,475→ 6,475 total
Award
Jazz Pharmaceuticals plc$JAZZ
Ordinary Shares
2021-02-25+2,590→ 2,590 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Common Stock
2020-11-16+3,576→ 3,576 total
Exercise/Conversion
BridgeBio Pharma, Inc.$BBIO
Restricted Stock Units
2020-11-16−3,576→ 3,576 total
Award
Denali Therapeutics Inc.$DNLI
Restricted Stock Units
2020-06-03+3,253→ 3,253 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2020-06-03+15,183→ 15,183 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2020-06-02+112,422→ 112,422 total
Award
BridgeBio Pharma, Inc.$BBIO
Stock Option (right to buy)
2019-12-12+82,878→ 82,878 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2019-05-30+27,245→ 27,245 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2018-11-06+50,044→ 50,044 total

Companies

Recent Filings

Address

C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250

PALO ALTO, CA, 94304

View on SEC.gov